Accumulation of PMN in tissues is a characteristic feature 1A of inflammation . PMN stimulates and amplifies additional migration of cells, and one possible mechanism by which this occurs is the production of rytokines by the same PMN . Evidence from a number of laboratories (for a review see reference 1), has shown that PMN can synthesize a selective range of cytokines when given the appropriate stimuli. Our own in vitro studies demonstrated that, upon stimulation with LPS, or after phagocytosis of yeast particles opsonized with IgG (Y-IgG), PMN are capable of expressing the genes and secreting newly synthesized IL-8 (2), TNF (3), and IL-10 (4) . These three rytokines have a critical role in the regulation of PMN recruitment, and also of many PMN functions directed against the offending agent to be eliminated (5) (6) (7) .
IL-10 is a recently characterized cytokine (8, 9 ) that has been implicated in the regulation of the functions of lymphoid and myeloid cells (10) because of its ability to suppress the synthesis of proinflammatory cytokines from T cells (9) and monocytes/macrophages (11) (12) (13) . In this study, we show that IL-10 is a potent inhibitor of proinflammatory cytokine release by PMN stimulated with LPS, suggesting that IL-10 may also have an important regulatory role in limiting the duration and extent of acute inflammatory response.
Materials and Methods
Cell Purification and Culture. Highly purified (>99 .5%) PMN were isolated under endotoxin-free conditions from buffy coats of healthy donors, as previously described (2-4). Immediately after purification, PMN were suspended in RPMI-1640 medium supplemented with 10% low endotoxin FCS (<0.006 ng/ml, Irvine Scientific, Santa Ana, CA) in the presence or not of purified recombinant human IL-10 (kindly provided by Dr. K. Moore, DNAX and Schering-Plough Corporation, Palo Alto, CA), and were then cultured at 37°C, either in 24-well tissue culture plates (Nunc, Roskilde, Denmark) at 106/300 P.1, or in polystyrene flasks (Greiner, Nurtingen, FRG) at 5-106/ml. Stimuli were usually added to the cells at the following doses : 1 14g/ml LPS (fromEscherichia coli 026:136, purchased from SigmaChemical Co., St. Louis, MO); 5 ng/ml TNF (purchased from Bachem Inc., Hannover, Germany); 20 ng/ml IL-10 (obtained from Hazleton Laboratories, Vienna, VA) ; and heat-killed yeast particles opsonized with IgG (YIgG) at a particle/cell ratio of 2:1(2-4) . In selected experiments, neutralizing mAbs against TNF (1.154.2) (14) and IL-1f6 (609.9) (15) , and an isotype-matched control mAb for 13.154.2 and 609 .9, 21110 (16), were used. Cell-free supernatants for cytokine determination were harvested at predetermined times, spun at 2,000 rpm for 30 s, and stored at -70°C.
RNA Isolation and Northern Blot Analysis. Total RNA was extracted from PMN and analyzed as already described (2) (3) (4) . mRNAs for TNF, IL-10,11-8, and actin, were detected by autoradiography after hybridization of nylon filters with 3 'P-labeled cDNA fragments (Ready to go-DNA labelling kit ; Pharmacia, Uppsala, Sweden) .
Cytokine Assays. Antigenic TNF was determined in the cellfree supernatants by using a double-ligand immunoassay (50 pg/ml detection limit)-{4) . Extracellular antigenic IL-8 was measured by a specific ELISA, having a detection limit of 20 pg/ml (2) . IL-10 was determined by a double-determinant RIA developed with mAbs 609 and 206 (50 pg/ml detection limit) (4, 15) .
Superoxide Anion (02 -) Production. This was performed exactly as described previously (17).
Statistical Analysis. Data are expressed as means ± SEM. Statistical evaluation was performed by the Student's t test for paired data and considered significant if p values were <0.05 .
Results and Discussion
IL-10 Inhibits the Production of TNF, IL-1/3, and IL-8 by Human PMN Stimulated with LPS. To determine whether IL-10 had any effect on the neutrophil production of IL-8, TNF, and IL-1f3, PMN were preincubated with IL-10 (100 U/ml) for 45 min and then stimulated with LPS for up to 18 h (Fig. 1 ). The accumulation of IL-8 upon LPS stimulation was already significantly elevated after 2 h, increased slightly over the next 4-6 h, and then rose dramatically up to 18 h. TNF levels in response to LPS were detectable after 2 h, peaked at the 6-h time point, and thereafter decreased. The first significant levels of IL-1f3 were detected at 3-4 h and then continued to rise up to 18 h. This pattern ofcytokine secretion by PMN was consistent with results previously IL-8 TN F 2208 IL-10 Inhibits PMN Cytokine Release shown by us (2) (3) (4) 17) , and by other investigators (18-21). Even though after 2-3 h of LPS stimulation IL-10 did not influence IL-8 release (5 t 3% inhibition, n = 8), at 6 h it markedly suppressed the accumulation of IL-8 (by 44 ± 23%, p <0.05, n = 9), and even more at 18 h (by 69 ± 13%, p <0.05, n = 8) . Inhibition by IL-10 was greater if calculated on the basis of the increased accumulation of IL-8 from 2 to 6 h (79 ± 20% inhibition, p <0.05, n = 7), or from 6 to 18 h (86 ± 10% inhibition, p <0.05, n = 7) . The production of TNF and IL-1f3 was almost completely abrogated by IL-10 at all time points tested (Fig. 1) . Results similar to those just described were obtained in five other experiments in which IL-10 was added to PMN at the same time as LPS, and in two more in which LPS was used at 10 and 100 ng/ml (data not shown) . Other studies indicated that the inhibitory effects were dependent on the concentration ofIL-10 used: for IL-10, maximal inhibition was reached upon exposure of LPS-stimulated PMN to 10 U/ml IL-10, whereas for TNF and IL-8, maximal inhibition was reached at 100 U/ml IL-10 (data not shown) . To understand whether the inhibitory effect of IL-10 was selective for cytokine generation, we investigated the effect of IL-10 on neutrophil respiratory burst. PMN were incubated for 4 and 18 h with or without 100 U/ml IL-10, in the presence or not of IFN-y and LPS, which are known to potentiate PMN respiratory burst (22, 23). In these conditions, IL-10, contrary to what has been observed with PMA-stimulated mouse macrophages (13), did not significantly influence either the constitutive or the enhanced capability of PMN to produce 02 -in response to FMLP. Similar results were obtained if TNF was used as an activating agent, or if PMA was used as a triggering stimulus (data not shown) . Autocrine Role of TNF and IL-1f3for the LPS-stimulated IL-8 Production. Since IL-10 started to suppress the accumulation of IL-8 only after 5-6 h (Fig. 1) , we evaluated the possibility that the inhibitory effect was the result of the suppression ofTNF and IL-1,(3 secretion . Fig. 2 A shows that PMN were able to release IL-8 after stimulation with TNF, and much less with IL-1f3 (Fig. 2 B) . However, when TNF and IL-1l were added to PMN in combination, at any concentrations, including those observed to be released by LPS-stimulated PMN, they produced an additive, if not often a synergistic, effect on the release of IL-8 measured from 2 and up to 18 h ---w-LPS -0-IG10+LPS IL-1 Effect ofIL-10 on LPSinduced release of IL-8, TNF, and IL-10 from PMN. PMN (106/300 Al) were preincubated with or without 100 U/ml IL-10 for 45 min and then cultured for up to 18 h after the addition of 1 Ftg/ml LPS . Released cytokines into the cell-free supernatants were measured by immunoassays as described in Material and Methods. Shown are the mean values ofduplicate assays from a single representative experiment out ofnine performed with similar results . of incubation (Fig . 2 B) . Remarkably, accumulation of IL-8 triggered by TNF, used alone (Fig. 2 A) or in combination with IL-19 (Fig. 2 B) , was unaffected by IL-10 . The effect on IL-8 release of anti-TNF and anti-IL-1(3 neutralizing Abs added to LPS-stimulated PMN either alone or in combination, was then investigated and compared with that of IL-10 . After 2 (data not shown) or 6 h (Fig. 2 C) , anti-TNF and/or anti-IL-1/3 Abs did not significantly influence the accumulation of IL-8 stimulated by LPS. However, over the remainder of the time course, the rise of IL-8 induced by LPS was significantly reduced by anti-IL-1(3 and anti-TNF Abs alone (by 25 ± 13% and 39 ± 11%, n = 3, respectively), and especially by the combination of the two Abs (by 64 .5 ± 12%, n = 3). This latter inhibition was comparable with that of IL-10 (81 ± 7%, n = 3) . Although we cannot exclude the role of other endogenous factors produced in response to LPS, for example IL-lot (21), or of the same IL-8 that induces itself in an autoregulatory fashion (2), collectively, these studies strongly indicate that the stimulus for IL-8 release provided by LPS to PMN is divided in two phases: an early one, directly induced by LPS itself and that can be inhibited by IFN--y (24), and a late, prolonged one, due to LPS-stimulated release of endogenous mediators, including TNF and IL-19 which play a fundamental role. Earlier observations in which IL-8 release by LPS-stimulated whole blood was examined, also identified a biphasic pattern of IL-8 production in that system, and attributed a mediating role to endogenous TNF and IL-1(25) . The data reported herein identify the PMN as one of the cell types responsible for this 2209 Cassatella et al . Brief Definitive production, and strengthen the relationship between the endogenous release of TNF and IL-10 and the late wave of IL-8 release . Importantly, in conditions in which production of TNF or IL-1(3 does not occur, as observed in the case of FMLPstimulated PMN, the release of IL-8 peaks at 2-3 h and then rapidly decreases to basal levels (17). E$ect of IL-10 on Cytokine mRNA Accumulation Induced by LPS To determine at which level IL-10 inhibited the production of cytokines, Northern blot analyses were performed on total RNA isolated from PMN preincubated with IL-10 and stimulated for different times with LPS . As shown in Fig.  3 , and in agreement with previous observations (2-4, 17-21), stimulation of PMN with LPS resulted in enhanced mRNA expression for TNF, IL-10, and IL-8 . To our surprise, IL-10 did not inhibit the LPS-induced upregulation of cytokine mRNAs at their onset (2 h), but was effective at later time points (>4 h) . These findings would suggest that the negative action of IL-10 on PMN cytokine production could be attributed to different mechanisms, not necessarily mutually exclusive : some acting, for example, at the level of cytokine mRNA stability, or others acting at the level of cytokine translation or secretion . A recently published (26) extensive analysis on the mechanisms of the suppressive effects of IL-10 on the capacity of mouse macrophages to produce TNF and IL-1(3, would support our speculations . Phagocytosis . Fig . 4 shows that IL-10 also decreased Y-IgGinduced cytokine accumulation . The most suppressive effect at 18 h was exerted on IL-10 (69 ± 12% inhibition, n = 4), whereas inhibitions of TNF (54 ± 18% inhibition, n = 5) and IL-8 (27 ± 18% inhibition, n = 4) were less pronounced, especially ifcompared with those obtained upon LPS stimulation . At the level of gene expression, the effects of IL-10 on the mRNA steady state levels of the cytokines under investigation were very similar to those described for LPS (data not shown) . Together with the observations previously described (2-4), it is once again evident that LPS and Y-IgG phagocytosis affect PMN cytokine production by distinct pathways, and, in the case of Y-IgG-stimulated IL-8 production, the autocrine role played by TNF and IL-10 is apparently not as determinant as for LPS.
In conclusion, the findings that IL-10 has a potent selective inhibitory effect on LPS-induced TNF, IL-10, and IL-8 production by human PMN, add new important properties to the numerous biological effects exerted by IL-10 on leukocytes (10), which could have clinical relevance . Recent data (27, 28) indicated that pretreatment with IL-10 prevents the toxicity of LPS in a murine model of endotoxic shock. Our results would suggest that inhibition of PMN cytokine production, in addition to the suppression of monokines, could presumably contribute to IL-10-mediated protection from lethal endotoxemia.
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